Commissioning recommendations
Recommendations for commissioning medicines and technologies where there is no NICE or national guidance, and resources to support the implementation of NICE Technology Appraisals.
Bazedoxifene plus conjugated oestrogens (Duavive®).pdf
Bevacizumab (Avastin®) in AMD briefing.pdf
Brimonidine tartrate gel (Mirvaso®) for the treatment of facial erythema.zip
Cannabis: Unlicensed cannabis-based medicines - Statement on prescribing in primary care.pdf
Dibotermin alfa for the management of acute tibial fractures in adults v3.pdf
Eltrombopag for thrombocytopenia in patients with Hepatitis C infection.pdf
EXOGEN® ultrasound bone healing system.zip
Immune Check Point Inhibitor Induced Colitis.pdf
Insulin degludec (Tresiba®).pdf
Insulin glargine 300 units_ml - Toujeo®.pdf
Iron chelators for iron overload in Myelodysplastic syndrome.pdf
IQoro neuromuscular training device.pdf
Liothyronine oral (all indications).pdf
Naltrexone and bupropion (Mysimba®) for obesity.pdf
Novel nicotine containing devices.pdf
Oxygen in cluster headaches.pdf
PCSK9 inhibitors Alirocumab and Evolocumab.zip
Psoriasis - biologic treatment of localised severe psoriasis.zip
Rifaximin for the management of chronic diarrhoea associated with gastro-intestinal disorders.pdf
Sodium oxybate (Xyrem®) in the management of narcolepsy with cataplexy in adults.zip
Thuasne Action Reliever Knee brace.pdf
Tolvaptan (Samsca®) for hyponatraemia secondary to SIADH.pdf
